Yu J - Search Results

1

Off-the-shelf CAR-engineered natural killer cells targeting FLT3 enhance killing of acute myeloid leukemia.

Mansour AG, Teng KY, Li Z, Zhu Z, Chen H, Tian L, Ali A, Zhang J, Lu T, Ma S, Lin CM, Caligiuri MA, Yu J. Mansour AG, et al. Among authors: yu j. Blood Adv. 2023 Oct 24;7(20):6225-6239. doi: 10.1182/bloodadvances.2022007405. Blood Adv. 2023. PMID: 37379267 Free PMC article.

2

PKR induces TGF-β and limits oncolytic immune therapy.

Hong B, Sahu U, Mullarkey MP, Hong E, Pei G, Yan Y, Otani Y, Banasavadi-Siddegowda Y, Fan H, Zhao Z, Yu J, Caligiuri MA, Kaur B. Hong B, et al. Among authors: yu j. J Immunother Cancer. 2023 Feb;11(2):e006164. doi: 10.1136/jitc-2022-006164. J Immunother Cancer. 2023. PMID: 36796878 Free PMC article.

3

Potent NKT cell ligands overcome SARS-CoV-2 immune evasion to mitigate viral pathogenesis in mouse models.

Lu H, Liu Z, Deng X, Chen S, Zhou R, Zhao R, Parandaman R, Thind A, Henley J, Tian L, Yu J, Comai L, Feng P, Yuan W. Lu H, et al. Among authors: yu j. PLoS Pathog. 2023 Mar 24;19(3):e1011240. doi: 10.1371/journal.ppat.1011240. eCollection 2023 Mar. PLoS Pathog. 2023. PMID: 36961850 Free PMC article.

4

Application of natural killer immunotherapy in blood cancers and solid tumors.

Sayegh M, Ma S, Yu J. Sayegh M, et al. Among authors: yu j. Curr Opin Oncol. 2023 Sep 1;35(5):446-452. doi: 10.1097/CCO.0000000000000968. Epub 2023 Jul 10. Curr Opin Oncol. 2023. PMID: 37551952 Free PMC article. Review.

5

Recent advances and remaining challenges in lung cancer therapy.

Barr T, Ma S, Li Z, Yu J. Barr T, et al. Among authors: yu j. Chin Med J (Engl). 2024 Mar 5;137(5):533-546. doi: 10.1097/CM9.0000000000002991. Epub 2024 Feb 7. Chin Med J (Engl). 2024. PMID: 38321811 Free PMC article. Review.

6

Isolation, expansion, and adoptive transfer of human ILC2s for the treatment of mice bearing liquid and solid tumors.

Li Z, Ma R, Tang H, Caligiuri MA, Yu J. Li Z, et al. Among authors: yu j. STAR Protoc. 2024 Sep 20;5(3):103096. doi: 10.1016/j.xpro.2024.103096. Epub 2024 Jul 31. STAR Protoc. 2024. PMID: 39088329 Free PMC article.

7

Reduction of myeloid-derived suppressor cells in prostate cancer murine models and patients following white button mushroom treatment.

Wang X, Ma S, Twardowski P, Lau C, Chan YS, Wong K, Xiao S, Wang J, Wu X, Frankel P, Wilson TG, Synold TW, Presant C, Dorff T, Yu J, Sadava D, Chen S. Wang X, et al. Among authors: yu j. Clin Transl Med. 2024 Oct;14(10):e70048. doi: 10.1002/ctm2.70048. Clin Transl Med. 2024. PMID: 39390760 Free PMC article.

8

YTHDC1 is a therapeutic target for B-cell acute lymphoblastic leukemia by attenuating DNA damage response through the KMT2C-H3K4me1/me3 epigenetic axis.

Li X, Zheng M, Ma S, Nie F, Yin Z, Liang Y, Yan X, Wen W, Yu J, Liang Y, Huang S, Han H. Li X, et al. Among authors: yu j. Leukemia. 2024 Nov 5. doi: 10.1038/s41375-024-02451-z. Online ahead of print. Leukemia. 2024. PMID: 39501105

9

Targeting cancer stem cells in multiple myeloma.

Gunes EG, Gunes M, Yu J, Janakiram M. Gunes EG, et al. Among authors: yu j. Trends Cancer. 2024 Aug;10(8):733-748. doi: 10.1016/j.trecan.2024.06.002. Epub 2024 Jul 5. Trends Cancer. 2024. PMID: 38971642 Free article. Review.

10

SARS-CoV-2 Nsp5 Demonstrates Two Distinct Mechanisms Targeting RIG-I and MAVS To Evade the Innate Immune Response.

Liu Y, Qin C, Rao Y, Ngo C, Feng JJ, Zhao J, Zhang S, Wang TY, Carriere J, Savas AC, Zarinfar M, Rice S, Yang H, Yuan W, Camarero JA, Yu J, Chen XS, Zhang C, Feng P. Liu Y, et al. Among authors: yu j. mBio. 2021 Oct 26;12(5):e0233521. doi: 10.1128/mBio.02335-21. Epub 2021 Sep 21. mBio. 2021. PMID: 34544279 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46,220 results

Search Page

Filters